Definitive Healthcare Corp. $DH Shares Acquired by Connor Clark & Lunn Investment Management Ltd.

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 70.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 250,152 shares of the company's stock after buying an additional 103,529 shares during the period. Connor Clark & Lunn Investment Management Ltd. owned about 0.23% of Definitive Healthcare worth $723,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in DH. Irenic Capital Management LP boosted its holdings in Definitive Healthcare by 9.2% during the fourth quarter. Irenic Capital Management LP now owns 7,003,194 shares of the company's stock worth $28,783,000 after buying an additional 590,009 shares in the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in Definitive Healthcare during the fourth quarter worth about $1,181,000. Two Sigma Investments LP boosted its holdings in Definitive Healthcare by 2,383.1% during the fourth quarter. Two Sigma Investments LP now owns 285,555 shares of the company's stock worth $1,174,000 after buying an additional 274,055 shares in the last quarter. Pinnacle Associates Ltd. purchased a new stake in Definitive Healthcare during the first quarter worth about $751,000. Finally, Pinnacle Wealth Management Advisory Group LLC purchased a new stake in Definitive Healthcare during the first quarter worth about $751,000. Hedge funds and other institutional investors own 98.67% of the company's stock.

Definitive Healthcare Price Performance

Shares of NASDAQ DH traded up $0.29 on Friday, hitting $4.06. The company's stock had a trading volume of 367,584 shares, compared to its average volume of 464,491. Definitive Healthcare Corp. has a 12-month low of $2.15 and a 12-month high of $5.68. The company has a market capitalization of $581.15 million, a price-to-earnings ratio of -1.53, a price-to-earnings-growth ratio of 5.79 and a beta of 1.64. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.65 and a quick ratio of 1.65. The stock has a 50 day moving average of $3.93 and a 200-day moving average of $3.54.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. BTIG Research downgraded shares of Definitive Healthcare from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Robert W. Baird set a $4.00 price objective on shares of Definitive Healthcare in a report on Friday, August 8th. Wall Street Zen raised shares of Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. The Goldman Sachs Group upped their price target on shares of Definitive Healthcare from $3.00 to $3.40 and gave the company a "neutral" rating in a report on Monday, May 12th. Finally, Stifel Nicolaus upped their price target on shares of Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a report on Friday, August 8th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Definitive Healthcare currently has an average rating of "Hold" and a consensus price target of $4.73.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.